ライフサイエンスコーパス: recombinant DNA

1 after transfection of CEMx174 cells with the recombinant DNA.

2 with purities approaching 90%, from a single recombinant DNA.

3 e-boost regimens with adjuvanted proteins or recombinant DNA.

4 In order to address these concerns, the Recombinant DNA Advisory Committee (RAC) held a symposiu

5 an UCLA Human Subject Protection Committee, Recombinant DNA Advisory Committee, and FDA-approved cli

6 macaques in the form of either purified VLP, recombinant DNA and canarypox (ALVAC) vectors engineered

7 easing database of natural enzyme diversity, recombinant DNA and fermentation technologies that allow

8 ical advances, among them the development of recombinant DNA and its many applications, opened the wa

9 Recombinant DNA and modified vaccinia virus Ankara (rMVA

10 Recently, however, recombinant DNA and molecular phylogenetic techniques ha

11 emonstrate that prime-boost vaccination with recombinant DNA and MVA vectors can induce multifunction

12 For example, recombinant DNA and PCR are powerful tools used to isola

13 Using recombinant DNA and proteins in vitro, we demonstrate th

14 ical sciences spurred on by the discovery of recombinant DNA and the advent of automated DNA sequenci

15 ogies concurrent with the development of new recombinant DNA approaches have enabled the extension of

16 n of native chemical ligation technology and recombinant DNA approaches that are amenable to the in-c

17 Using recombinant DNA approaches, we demonstrated that the hem

18 al CPE deletion fragments was constructed by recombinant DNA approaches.

19 Purified recombinant DNAs are then injected into 1-2-cell zebrafi

20 echnologies such as combinatorial chemistry, recombinant DNA as well as computational multi-scale met

21 This recombinant DNA-B component, which contained the ToMoV o

22 infection in a chimpanzee HBV carrier using recombinant DNA-based immunization followed by a recombi

23 large intersubspecific cross, a panel of 53 recombinant DNAs between D15Mit29 and D15Mit2 has been a

24 Unlike the full-length ER, the recombinant DNA binding domain of ER did not discriminat

25 The recombinant DNA-binding antibody, called Fab-E box, bind

26 Full-length (67 kDa) ER or its 11 kDa recombinant DNA-binding domain (ER-DBD) is also suscepti

27 Recombinant DNA-binding protein B binds the selenocystei

28 Monoclonal antibodies and recombinant DNA biopharmaceuticals are derived from rela

29 mbryonic stem (ES) cells, transfected with a recombinant DNA consisting of a fatty acid-binding prote

30 expression vectors were used to introduce a recombinant DNA construct containing enhanced green fluo

31 Our system uses a recombinant DNA construct in which the coding sequences

32 adenovirus vectors were used to introduce a recombinant DNA construct, containing the enhanced green

33 ering RNA (siRNA) duplexes within cells from recombinant DNA constructs, because this might allow lon

34 Recombinant DNA controls for each of these organisms wer

35 Using a recombinant DNA-derived alpha-neurotoxin (Naja mossambic

36 a day along with subcutaneous injections of recombinant DNA-derived insulin.

37 The assembly of large recombinant DNA encoding a whole biochemical pathway or

38 ve been reported previously after expressing recombinant DNAs, encoding CYP17 from various species, i

39 lating EMMPRIN expression and activity using recombinant DNA engineering and neutralizing antibodies.

40 should improve the efficiency of performing recombinant DNA experiments in Gram-positive bacteria.

41 pORT plasmid vectors designed to facilitate recombinant DNA exploitation.

42 his study with native, wild-type, and mutant recombinant DNA-expressed AChEs, each inhibited by repre

43 ation of the integrin alpha(IIb)beta(3) in a recombinant DNA expression model, and show that 14-3-3 i

44 es either in vitro or in vivo using standard recombinant DNA expression techniques.

45 An immunization protocol using injection of recombinant DNA followed by injection of recombinant mod

46 eterologous prime-boost vaccine regimen used recombinant DNA for priming and recombinant modified vac

47 uch greater versatility in the generation of recombinant DNA for the purposes of synthetic biology.

48 to the apoptotic changes in nuclei by using recombinant DNA fragmentation factor (DFF), a heterodime

49 Production of recombinant DNA in bacterial cells is an essential techn

50 rom natural sources and by overexpression of recombinant DNA in Escherichia coli.

51 g molecular mechanism for the integration of recombinant DNA into the genome of most eukaryotic syste

52 Microinjection of recombinant DNA into zygotic pronuclei has been widely u

53 een included, which permits linearization of recombinant DNA irrespective of the characteristics of t

54 he presence of neither the GM strain nor its recombinant DNA is allowed for fermentation products pla

55 the goal of selecting, retrieving, and using recombinant DNA is exemplified by simple visual-based co

56 We also discuss the disposal of recombinant DNA, its persistence in the environment and

57 ell development within GCs, we constructed a recombinant DNA library enriched for cDNAs derived from

58 h the 5p maps of other groups using the same recombinant DNA library, a comprehensive map was constru

59 ey assumption-for a large randomly generated recombinant DNA library, there exists a staircase of DNA

60 Recombinant DNA ligase III was a substrate for calpain d

61 ponge'-based approaches, for which extensive recombinant DNA manipulation is required.

62 Epitope tagging is a recombinant DNA method by which a protein encoded by a c

63 ange of lengths of polyglutamine produced by recombinant DNA methodology by constructing a library of

64 SIT programs could be overcome by the use of recombinant DNA methods and molecular genetics.

65 ctionally active scIL5 was constructed using recombinant DNA methods by linking two IL5 monomers with

66 Recent developments have utilized recombinant DNA methods to prepare artificial protein hy

67 Recombinant DNA methods were used to create artificial p

68 Recombinant DNA methods were used to make the Streptococ

69 Specifically, recombinant DNA methods were used to prepare a protein t

70 or-intensive and time-consuming hybridoma or recombinant DNA methods.

71 y, misapprehensions and misinformation about recombinant DNA-modified (also known as 'genetically mod

72 For decades, in most regulatory frameworks, recombinant DNA-modified organisms have been the wrong f

73 mechanism is the lack of a system in which a recombinant DNA molecule undergoes cytokine-regulated cl

74 sing the same approach and that interspecies recombinant DNA molecules can produce a biologically fun

75 acts to assemble multiple DNA fragments into recombinant DNA molecules in a single in vitro recombina

76 ating plasmid, and introducing the resulting recombinant DNA molecules into bacteria.

77 ides a means for the in vivo construction of recombinant DNA molecules that may be problematic to ass

78 Efficient formation of recombinant DNA molecules was observed in ruvC+ recG+, r

79 ate the rapid and systematic construction of recombinant DNA molecules.

80 , that facilitates the rapid construction of recombinant DNA molecules.

81 keys were intramuscularly primed with either recombinant DNA (n = 4) or modified vaccinia virus Ankar

82 ays could reproducibly detect 10 copies of a recombinant DNA plasmid containing a partial region of t

83 We designed recombinant DNA plasmids encoding soluble multitrimers o

84 Recombinant DNA pol delta was also purified by immunoaff

85 Species-specific 16S recombinant DNA polymerase chain reaction assays targeti

86 Recombinant DNA polymerase delta efficiently replicated

87 mmunoprecipitation experiments revealed that recombinant DNA polymerase epsilon directly interacts wi

88 me into the public policy debates regarding recombinant DNA practices.

89 report unique mechanistic characteristics of recombinant DNA primase from Bacillus anthracis.

90 Here we examined recombinant DNA priming followed by subunit protein boos

91 ce in situ hybridization (FISH) using large, recombinant DNA probes consisting of contiguous genomic

92 nts a substantial advance in high-throughput recombinant DNA production that will save time, effort a

93 Plasma-derived and recombinant DNA products currently have good viral safet

94 Since 1987, dozens of purified recombinant DNA products derived from CCLs have been dev

95 ons, genetic recombination, formation of new recombinant DNA products, and the presence of both drug

96 cobacterium bovis BCG (rBCG), electroporated recombinant DNA (rDNA) along with an interleukin-12 (IL-

97 f different origins is fundamental to modern recombinant DNA research.

98 , the extraordinarily exciting time when the recombinant DNA revolution hit yeast genetics.

99 CR cassettes facilitates the introduction of recombinant DNA sequences into the lambda-phage genome w

100 le and exportable forms of neuroligin-1 from recombinant DNA sources, by truncating the protein befor

101 to re-form a 3'-5' phosphodiester bond in a recombinant DNA strand.

102 t study with isogenic strains constructed by recombinant DNA strategies unambiguously documented that

103 analyzed in vitro using purified protein and recombinant DNA substrates that model the U3 and U5 ends

104 chain reaction (PCR) amplification of a 16S recombinant DNA target, and a mouse infectivity assay.

105 Here, we apply a recombinant DNA technique to investigate the role of dop

106 ted a single-headed dimer of L7/L12 by using recombinant DNA techniques and chemical cross-linking.

107 s study, AF17121 was fused to thioredoxin by recombinant DNA techniques and examined for IL5Ralpha in

108 biological control agents but development of recombinant DNA techniques has made it possible to signi

109 A number of new recombinant DNA techniques have been developed for genet

110 Recombinant DNA techniques have been used to add 14 amin

111 Development of recombinant DNA techniques in the 1970s and their applic

112 east for beta-keto ester reductions by using recombinant DNA techniques to alter the levels of three

113 part of my laboratory was using the then-new recombinant DNA techniques to clone and characterize man

114 + ... Cu1.5+ structure through spectroscopy, recombinant DNA techniques, and crystallography.

115 Using recombinant DNA techniques, we have identified the epito

116 Using recombinant DNA techniques, we prepared a fusion protein

117 m genomic DNA, and thus more quickly than by recombinant DNA techniques.

118 onsive control ELP in Escherichia coli using recombinant DNA techniques.

119 peptide, a fusion protein was produced using recombinant DNA techniques.

120 the family II CBD (E4-74) were made by using recombinant DNA techniques.

121 y of developing molecular computers based on recombinant DNA techniques.

122 tive pharmaceutical ingredients derived from recombinant DNA technologies and as a method to detect c

123 sis for improved approaches to gene-chip and recombinant DNA technologies and provide new insight int

124 Monoclonal antibody and recombinant DNA technologies have led to the development

125 Recombinant DNA technologies have opened the possibility

126 tome sequencing, mass spectrometry (MS), and recombinant DNA technologies were applied to characteriz

127 loned, and its expression was analyzed using recombinant DNA technologies.

128 ng methods and as bispecific diabodies using recombinant DNA technologies.

129 conjugation (GnRH-PAP conjugate) or through recombinant DNA technology (GnRH-PAP fusion).

130 The advent of recombinant DNA technology allowed the expression of EPO

131 Application of recombinant DNA technology and electrophysiology to the

132 nd alphaB-crystallins) have been prepared by recombinant DNA technology and shown to differ in the fo

133 for preventive allergy vaccination based on recombinant DNA technology and synthetic peptide chemist

134 ve helped to perpetuate 'The Big Lie' - that recombinant DNA technology applied to agriculture and fo

135 The framing of agricultural products of recombinant DNA technology as GMOs lacks biological cohe

136 iction endonucleases are used prevalently in recombinant DNA technology because they bind so stably t

137 ns (HCPs) in biopharmaceuticals derived from recombinant DNA technology can present potential safety

138 The advent of recombinant DNA technology changed this dramatically in

139 GMAP represents a recombinant DNA technology designed for widespread circu

140 designer low O(2) affinity Hbs generated by recombinant DNA technology for applications as Hb based

141 ority of chemical synthetic strategies used, recombinant DNA technology has allowed for the productio

142 At the same time, remarkable progress in recombinant DNA technology has enabled the development o

143 In the past 30 yr, introduction of recombinant DNA technology has facilitated the dissectio

144 The recent advances in recombinant DNA technology have begun to help to elucida

145 The contribution of recombinant DNA technology in defining the molecular pat

146 ch plakoglobin or parts thereof, produced by recombinant DNA technology in E. coli, are exposed to mo

147 The advent of recombinant DNA technology made it possible to overcome

148 The emergence of recombinant DNA technology occurred via the appropriatio

149 proteins produced in different host cells by recombinant DNA technology often contain terminal GlcNAc

150 The production of proteins via recombinant DNA technology often requires the in vitro f

151 Recombinant DNA technology permits large-scale, low-cost

152 wild-type S. flexneri 2a by rational use of recombinant DNA technology that achieves a remarkable de

153 estriction enzymes (e.g. EcoRI) gave rise to recombinant DNA technology that has transformed molecula

154 In the present studies, we applied the recombinant DNA technology to prepare native, unmodified

155 successful drug spawned by the revolution in recombinant DNA technology".

156 Using recombinant DNA technology, 5C12 isotype variants (IgG1,

157 sessment of compounds, the implementation of recombinant DNA technology, and large-scale manufacture

158 Unlike recombinant DNA technology, embryonic stem cell research

159 locyte colony-stimulating factor produced by recombinant DNA technology, is frequently used to stimul

160 n drug development (using such techniques as recombinant DNA technology, site-directed mutagenesis, p

161 Through recombinant DNA technology, the alphavirus RNA replicati

162 Using recombinant DNA technology, the present study provides t

163 Before the application of recombinant DNA technology, these two alpha-crystallin s

164 Recombinant DNA technology, which is based on the assemb

165 ated since their successful production using recombinant DNA technology.

166 biological research is highly dependent upon recombinant DNA technology.

167 to prevent these complications by the use of recombinant DNA technology.

168 inhibitor, turkey ovomucoid third domain, by recombinant DNA technology.

169 ecombine genes from different pathways using recombinant DNA technology.

170 ) were fused to the Fc portion of IgG1 using recombinant DNA technology.

171 red from mammalian cell cultures by means of recombinant DNA technology.

172 lagellin protein of S. typhi was prepared by recombinant DNA technology.

173 End ligase activity may have applications in recombinant DNA technology.

174 It is a live vaccine developed using recombinant DNA technology.

175 ns, but only a few LAB have been modified by recombinant-DNA technology because of consumer resistanc

176 ch for the rapid and efficient generation of recombinant DNA that can be used for parallel processing

177 y laboratory developed a method for creating recombinant DNAs that led us and others, over the next t

178 The EcoRI endonuclease is an important recombinant DNA tool and a paradigm of sequence-specific

179 owth rate, culture conditions, and available recombinant DNA tools.

180 ted from a 55-year-old male with OAC without recombinant-DNA transformation.

181 mors could markedly affect the expression of recombinant DNA under control of both inducible and cons

182 he cell-mediated immune profile induced by a recombinant DNA vaccine was assessed in the simian/HIV (

183 useful for future rational designs of other recombinant DNA vaccines targeting tissue differentiatio

184 In this study, we used a recombinant DNA virus expressing different forms of a mo

185 rpesvirus type 2 (GHV-2) genomes, generating recombinant DNA viruses that now circulate in wild birds

186 llows efficient and reproducible assembly of recombinant DNA with as many as 5 and 10 fragments simul

187 io in the 1960s and 1970s, later followed by recombinant DNA work in the 1990s, which led to a reviva